Literature DB >> 9277482

Induction of tetrahydrobiopterin synthesis in rat cardiac myocytes: impact on cytokine-induced NO generation.

K Kasai1, Y Hattori, N Banba, S Hattori, S Motohashi, S Shimoda, N Nakanishi, S S Gross.   

Abstract

Because tetra-hydrobiopterin (BH4) is an essential cofactor for nitric oxide (NO) formation, we investigated whether BH4 synthesis is required for cytokine-induced NO production in cultured rat cardiac myocytes. The total biopterin content of untreated cardiac myocytes was below our limit of detection. However, treatment with interleukin-1 alpha (IL-1 alpha) + interferon-gamma (IFN-gamma) caused a significant rise in biopterin levels and induced NO synthesis. 2,4-Diamino-6-hydroxypyrimidine (DAHP), a selective inhibitor of GTP cyclohydrolase I (the rate-limiting enzyme for de novo BH4 synthesis), completely abolished the elevation in biopterin levels induced by IL-1 alpha + IFN-gamma. DAHP also caused a concentration-dependent inhibition of (IL-1 alpha + IFN-gamma)-induced NO synthesis. Similarly, N-acetylserotonin, an inhibitor of the BH4 synthetic enzyme sepiapterin reductase, blocked increases in biopterin levels as well as NO synthesis induced by IL-1 alpha + IFN-gamma. Sepiapterin, substrate for BH4 synthesis via the pterin salvage pathway, prevented this inhibition by DAHP or N-acetylserotonin, and this effect was blocked by methotrexate. Sepiapterin and, to a lesser extent, BH4 dose dependently enhanced (IL-1 alpha + IFN-gamma)-induced NO synthesis, suggesting that the concentration of BH4 limits the rate of NO production. Inducible NO synthase mRNA and GTP cyclohydrolase I mRNA were induced by IL-1 alpha + IFN-gamma in parallel. We thus demonstrate that BH4 synthesis is an absolute requirement for induction of NO synthesis by cytokines in cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9277482     DOI: 10.1152/ajpheart.1997.273.2.H665

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Role of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats.

Authors:  Jianzhong An; Jianhai Du; Na Wei; Hao Xu; Kirkwood A Pritchard; Yang Shi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

2.  Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes.

Authors:  Irina A Ionova; Jeannette Vásquez-Vivar; Jennifer Whitsett; Anja Herrnreiter; Meetha Medhora; Brian C Cooley; Galen M Pieper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-03       Impact factor: 4.733

3.  Cytokines and lipopolysaccharides induce inducible nitric oxide synthase but not enzyme activity in adult rat cardiomyocytes.

Authors:  Jeannette Vásquez-Vivar; Jennifer Whitsett; Irina Ionova; Eugene Konorev; Jacek Zielonka; Balaraman Kalyanaraman; Yang Shi; Galen M Pieper
Journal:  Free Radic Biol Med       Date:  2008-06-27       Impact factor: 7.376

4.  Blockade of tetrahydrobiopterin synthesis protects neurons after transient forebrain ischemia in rat: a novel role for the cofactor.

Authors:  S Cho; B T Volpe; Y Bae; O Hwang; H J Choi; J Gal; L C Park; C K Chu; J Du; T H Joh
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

5.  Increasing tetrahydrobiopterin in cardiomyocytes adversely affects cardiac redox state and mitochondrial function independently of changes in NO production.

Authors:  Savitha Sethumadhavan; Jennifer Whitsett; Brian Bennett; Irina A Ionova; Galen M Pieper; Jeannette Vasquez-Vivar
Journal:  Free Radic Biol Med       Date:  2016-01-27       Impact factor: 7.376

Review 6.  Recoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recycling.

Authors:  Matthew S Alkaitis; Mark J Crabtree
Journal:  Curr Heart Fail Rep       Date:  2012-09

Review 7.  Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension.

Authors:  José L Sánchez-Gloria; Horacio Osorio-Alonso; Abraham S Arellano-Buendía; Roxana Carbó; Adrián Hernández-Díazcouder; Carlos A Guzmán-Martín; Ivan Rubio-Gayosso; Fausto Sánchez-Muñoz
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

Review 8.  Sepiapterin reductase: Characteristics and role in diseases.

Authors:  Yao Wu; Peng Chen; Li Sun; Shengtao Yuan; Zujue Cheng; Ligong Lu; Hongzhi Du; Meixiao Zhan
Journal:  J Cell Mol Med       Date:  2020-07-30       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.